Host Factor-Targeted Hepatitis B Virus Therapies

Publisher： Karger

E-ISSN： 1423-0100|57|3-4|158-162

ISSN： 0300-5526

Source： Intervirology, Vol.57, Iss.3-4, 2014-07, pp. : 158-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alcoholic hepatitis: Translational approaches to develop targeted therapies

By  

HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. : 1343-1355

John Wiley & Sons Inc

Access to resources Recommend Favorite

A window of opportunity: declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination

By Oliveira Sabrina A. N.   Hacker Mariana A.   Oliveira M. Lourdes A.   Yoshida Clara F. T.   Telles Paulo R.   Bastos Francisco I.  

Revista Panamericana de Salud Pública/Pan American Journal of Public Health, Vol. 18, Iss. 4-5, 2005-10 ,pp. : 271-277

Pan American Health Organization (PAHO)

Access to resources Recommend Favorite

Hepatitis B Virus

By  

Transfusion Medicine and Hemotherapy, Vol. 32, Iss. 3-4, 2005-08 ,pp. : 151-159

Karger

Access to resources Recommend Favorite

Hepatitis B Virus

By  

Transfusion Medicine and Hemotherapy, Vol. 27, Iss. 5, 2000-10 ,pp. : 226-234

Karger

Access to resources Recommend Favorite

Hepatitis E virus and fulminant hepatitis–a virus or host‐specific pathology?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 4, 2015-04 ,pp. : 1334-1340

John Wiley & Sons Inc

Access to resources Recommend Favorite